Survival of high-risk pediatric neuroblastoma patients in a developing country

about

Survival of high-risk pediatric neuroblastoma patients in a developing country

Item

http://www.wikidata.org/entity/Q40731149

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Survival of high-risk pediatric neuroblastoma patients in a developing country

@en

type

Item

label

Survival of high-risk pediatric neuroblastoma patients in a developing country

@en

prefLabel

Survival of high-risk pediatric neuroblastoma patients in a developing country

@en

P1476

Survival of high-risk pediatric neuroblastoma patients in a developing country

@en

P2093

Alcira B Fynn

http://www.w3.org/2001/XMLSchema#string

Claudia Ruiz

http://www.w3.org/2001/XMLSchema#string

J Michael Conner

http://www.w3.org/2001/XMLSchema#string

Joseph C Easton

http://www.w3.org/2001/XMLSchema#string

Sergio Gomez

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study

Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

Survival analysis in infectious disease research: describing events in time

International collaboration on childhood leukemia.

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group.

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial.

High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update.

Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.

Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.

P304

825-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12731

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rohit P. Ojha

Peter H Asdahl

P577

2016-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27235336

http://www.w3.org/2001/XMLSchema#string

P932

5661966

http://www.w3.org/2001/XMLSchema#string